UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A

 
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
December 3, 2008

ASTRO-MED, INC
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

COMMISSION FILE NUMBER               0-13200
 
Rhode Island	05-0318215	
(State or Other Jurisdiction of Incorporation or Organization)	(IRS Employer Identification Number)	
600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
(401-828-4000)
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On December 3, 2008, Astro-Med, Inc. (the “Company”) issued a press release in which it disclosed unaudited financial information related to third quarter consolidated earnings. The Exhibit filed with Form 8-K dated December 3, 2008 was not the final release issued by the Company and contained incorrect numbers for the Company’s current ratio and current liabilities. A copy of the correct press release (as originally issued) is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 8.01 OTHER EVENTS
On December 4, 2008, the Company conducted a conference call to review its third quarter earnings release. On the call, the Company updated its previously issued earnings guidance for fiscal year 2009, indicating an expect range of annual sales of $74-$76 million and earnings per share of $0.45 to $0.50. The webcast can be accessed for the next five days at www.Astro-MedInc.com/webcast .
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(c)	Exhibit	
Exhibit no.	Exhibit	
99.1	Press Release dated December 3, 2008	
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.
 
DATE: December 4, 2008	ASTRO-MED, INC.	

 	By:	/s/ Joseph P. O’Connell	
 	______________________	
Joseph P. O’Connell
Senior Vice President, Treasurer and Chief Financial Officer

INDEX TO EXHIBITS

 
Exhibit No.	Exhibit	
 
99.1	Press Release Dated December 3, 2008	

 

Exhibit 99.1 
PRESS RELEASE

 
600 East Greenwich Avenue
West Warwick, Rhode Island 02893
 
For Immediate Release
 
Contact:	Albert W. Ondis, CEO	
 	Joseph P. O’Connell, CFO	December 3, 2008	
 	Astro-Med, Inc.	
 	(401) 828-4000	
 	www.astro-medinc.com	

Astro-Med Reports Third Quarter Financial Results;
Directors Declare Regular Cash Dividend
 
West Warwick, RI, December 3, 2008 -- Astro-Med, Inc. (NASDAQ:ALOT) reports net income of $649,000, equal to 9 cents per diluted share, on sales of $17,681,000 for the Third Quarter ended November 1, 2008. For the corresponding period of the prior year, Astro-Med reported net income of $1,562,000, equal to 21 cents per diluted share, on sales of $19,139,000. Net income in the prior year quarter included a tax benefit of approximately $446,000, or 6 cents per diluted share, due to favorable resolution of certain income tax examinations.
 
For the nine-month period of the current fiscal year, Astro-Med reported net income of $2,701,000, equal to 36 cents per diluted share on sales of $56,152,000, compared to net income of $2,969,000, equal to 39 cents per diluted share, on sales of $54,241,000 in the comparable nine-month period of the prior fiscal year. Net income for the nine-month period of the prior fiscal year included a tax benefit of approximately $446,000, or 6 cents per diluted share, due to the favorable resolution of income tax examinations.
 
Commenting on the results, Albert W. Ondis, Chief Executive Officer, said: “We are pleased to have achieved solid Third Quarter results despite the difficult current business climate. We continued our aggressive new product development program and maintained our renowned high level of customer support, while at the same time strengthening our powerful balance sheet by increasing our cash and marketable securities position to $22,093,000, improving our current ratio to 6.08 to 1, and remaining debt free. Our Gross Profit margins remained healthy at 43.3% and income from operations exceeded $1 million. And, we continued to pay cash dividends at the annual rate of 24 cents per share.”
 
Results for the nine month period of the current fiscal year reflect sales increases of 3.5%, gross profit increases of 6.4%, and an operating income increase of 19.1%. Favorable foreign exchange currency rates added approximately $798,000 to this

year’s nine-month sales. Favorable foreign exchange currency rates declined approximately $118,000 in this year’s Third Quarter sales.
 
New orders in the Third Quarter matched the first quarter’s orders at $18,301,000. While sales of Test & Measurement equipment increased by 9.3%, Third Quarter revenue from sales of Ruggedized cockpit printers was impacted by production delays in the Airbus 380 and Boeing 787 aircraft. QuickLabel Systems brand sales were affected by our customers’ cautious attitude toward making new purchases. Grass Technologies brand sales of sleep and most neurological instruments were strong in the Third Quarter, up 30.8% from the prior year. However, sales of Grass long-term monitoring products and products aimed at research applications lagged behind the previous year.
 
“We are very confident in Astro-Med’s future prospects with our industry-leading new and existing products, solid base of existing customers, strong profit margins, secure balance sheet, and worldwide recognition of our Astro-Med Test & Measurement, QuickLabel Systems, and Grass Technologies brands. Our organization is committed to success, and the Company will continue on its path of growth and profitability,” said Ondis.  
 
Astro-Med Directors Declare Regular Cash Dividend
 
On November 17, 2008, the Directors of Astro-Med declared the regular quarterly cash dividend of 6 cents per share, payable on January 2, 2009 to shareholders of record on December 12, 2008.
 
Third Quarter Conference Call to be held Thursday, December 4, 2008
 
The Astro-Med Third Quarter conference call will be held on Thursday, December 4, 2008, at 11:00 AM EST.  It will be broadcast in real time on the Internet. We invite investors and analysts to participate in the conference call by dialing in to 800-257-7087 or by listening to the web cast at www.Astro-MedInc.com/webcast . The webcast will be accessible for up to five days following the call.
 
Astro-Med, Inc.
 
Consolidated Statements of Operations
In Thousands Except for Per Share Data
(Unaudited)
 
 	Three-Months Ended	 	Nine-Months Ended	
 	November 1,
2008	November 3,
2007	 	November 1,
2008	November 3,
2007	
Net Sales	$17,681	$19,139	 	$56,152	$54,240	
Gross Profit	7,647	8,372	 
 	24,516	23,049	
 	43.3%	43.7%	 	43.7%	42.5%	
Operating Expenses:	 	 	 	 	 	
Marketing & Selling
Research & Development	4,164
1,254	4,270
1,184	 	12,928
3,680	12,618
3,417	
General & Administrative	1,140	1,180	 	3,595	3,392	
 	6,558	6,634	 	20,203	19,427	
 	 	 	 	 	 	
Operating Income	1,089	1,738	 	4,313	3,622	
 	6.2%	9.1%	 	7.7%	6.7%	

 
Other Income (Expense), Net	(237)	170	 	-	632	
 	 	 	 	 	 	
Income Before Taxes	852	1,908	 	4,313	4,254	
 	 	 	 	 	 	
Income Tax Provision	203	346	 	1,612	1,285	
 	 	 	 	 	 	
Net Income	$ 649	$ 1,562	 	$ 2,701	$ 2,969	
 	 	 	 	 	 	
Net Income Per Share - Basic	$ 0.09	$ 0.23	 	$ 0.39	$ 0.43	
Net Income Per Share - Diluted	$ 0.09	$ 0.21	 	$ 0.36	$ 0.39	
 	 	 	 	 	 	
Weighted Average Number of Common Shares - Basic	 
7,005	 
6,912	 	 
6,979	 
6,881	
Weighted Average Number of Common Shares - Diluted	 
7,471	 
7,510	 	 
7,478	 
7,552	
 	 	 	 	 	 	
Dividends Declared Per Common Share	$ 0.06	$ 0.05	 	$ 0.18	$ 0.15	

Selected Balance Sheet Data
In Thousands
Unaudited
 
 	As of
November 1, 2008
 	As of
January 31,  
2008	
Cash & Marketable Securities (1)
 	$22,093	$17,556	
Current Assets
 	$47,663	$48,384	
Total Assets
 	$61,846	$61,699	
Current Liabilities
 	$7,837	$8,973	
Shareholders’ Equity
 	$51,406	$49,355	
 
 	(1) Includes investment securities classified as non-current	

About Astro-Med, Inc.
Astro-Med, Inc. is a leading manufacturer of specialty high tech printing systems, electronic medical instrumentation, and test and measurement instruments. Astro-Med, Inc. products are sold under the brand names Astro-Med ® , Grass ® Technologies and QuickLabel ® Systems and are employed around the world in a wide range of aerospace, medical, military, industrial, and packaging applications. Astro-Med, Inc. is a member of the Russell Microcap ® Index. Additional information is available by visiting www.Astro-MedInc.com .
 
Safe Harbor Statement
This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein.   Factors that could affect these results include those mentioned in Astro-Med’s FY2008 annual report and its annual and quarterly filings with the Securities and Exchange Commission.